These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20096935)

  • 1. Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interaction.
    Bumpus NN; Hollenberg PF
    J Inorg Biochem; 2010 Apr; 104(4):485-8. PubMed ID: 20096935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mass-spectrometric identification of interaction sites between cytochrome P450 2B4 and NADPH cytochrome P450 reductase].
    Ivanov AV; Kopylov AT; Zgoda VG; Toropygin IIu; Khriapova EV; Ivanov IuD
    Biomed Khim; 2010; 56(1):40-54. PubMed ID: 21328910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450.
    Nadler SG; Strobel HW
    Arch Biochem Biophys; 1991 Nov; 290(2):277-84. PubMed ID: 1929397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing.
    Voznesensky AI; Schenkman JB
    J Biol Chem; 1992 Jul; 267(21):14669-76. PubMed ID: 1321814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase.
    Omata Y; Dai R; Smith SV; Robinson RC; Friedman FK
    J Protein Chem; 2000 Jan; 19(1):23-32. PubMed ID: 10882169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the interactions between cytochrome P450 2E1 and cytochrome b5 by mass spectrometry and site-directed mutagenesis.
    Gao Q; Doneanu CE; Shaffer SA; Adman ET; Goodlett DR; Nelson SD
    J Biol Chem; 2006 Jul; 281(29):20404-17. PubMed ID: 16679316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of interaction between cytochrome P450 2B4 and cytochrome b5: the first evidence of two mutual orientations.
    Sulc M; Jecmen T; Snajdrova R; Novak P; Martinek V; Hodek P; Stiborova M; Hudecek J
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():41-7. PubMed ID: 23353842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites.
    Kent UM; Mills DE; Rajnarayanan RV; Alworth WL; Hollenberg PF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):549-58. PubMed ID: 11805216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1993 Jul; 304(1):257-65. PubMed ID: 8323289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.
    Bumpus NN; Hollenberg PF
    Mol Pharmacol; 2008 Oct; 74(4):990-9. PubMed ID: 18621926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c.
    Shen AL; Kasper CB
    J Biol Chem; 1995 Nov; 270(46):27475-80. PubMed ID: 7499204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
    Bonina TA; Gilep AA; Estabrook RW; Usanov SA
    Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.
    Xiao Y; Shinkyo R; Guengerich FP
    Drug Metab Dispos; 2011 Jun; 39(6):944-6. PubMed ID: 21430234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of membrane-bound enzyme systems.
    Müller-Enoch D; Gruler H
    Z Naturforsch C J Biosci; 2000; 55(9-10):747-52. PubMed ID: 11098825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of mass spectrometry and heterologous expression for identification of membrane-interacting peptides in cytochrome P450 46A1 and NADPH-cytochrome P450 oxidoreductase.
    Mast N; Liao WL; Pikuleva IA; Turko IV
    Arch Biochem Biophys; 2009 Mar; 483(1):81-9. PubMed ID: 19161969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning, bacterial expression and functional characterisation of cytochrome P450 monooxygenase, CYP97C27, and NADPH-cytochrome P450 reductase, CPR I, from Croton stellatopilosus Ohba.
    Sintupachee S; Ngamrojanavanich N; Sitthithaworn W; De-Eknamkul W
    Plant Sci; 2014 Dec; 229():131-141. PubMed ID: 25443840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenodoxin interaction with adrenodoxin reductase and cytochrome P-450scc. Cross-linking of protein complexes and effects of adrenodoxin modification by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
    Lambeth JD; Geren LM; Millett F
    J Biol Chem; 1984 Aug; 259(16):10025-9. PubMed ID: 6432777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.
    Roberts ES; Hopkins NE; Alworth WL; Hollenberg PF
    Chem Res Toxicol; 1993; 6(4):470-9. PubMed ID: 8374044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.